Fasting insulin reveals how hard your pancreas must work to keep glucose normal. It rises years before glucose does, making it one of the earliest detectable warnings of insulin resistance.
Standard range versus optimal range
| Framework | Insulin value | Source |
|---|---|---|
| Standard lab reference | roughly 2-25 µIU/mL | Common laboratory range |
| Optimal metabolic health | below 5-6 µIU/mL | Metabolic research consensus |
| Suggestive of insulin resistance | above 12-15 µIU/mL fasting | HOMA-IR literature |
When it runs high
High fasting insulin with normal glucose means the pancreas is compensating for resistant tissues, a state called hyperinsulinemia. Beyond its link to future diabetes, elevated insulin itself is associated with cardiovascular disease, fatty liver and some cancers.
- Insulin resistance from abdominal fat, inactivity or excess calories
- Type 2 diabetes in its earlier compensated phase
- Certain medicines including steroids
- Rare insulin-producing tumors when glucose is simultaneously low
- Pregnancy and puberty, physiological states of resistance
When it runs low
Low fasting insulin is typical in lean, insulin-sensitive people and is desirable when glucose is normal. Low insulin together with high glucose signals that the pancreas can no longer produce enough, as in type 1 or late-stage type 2 diabetes.
- High insulin sensitivity, the favorable cause
- Type 1 or LADA diabetes when glucose runs high
- Advanced beta cell exhaustion in long-standing diabetes
- Pancreatic disease
The number that moves first
In the natural history of type 2 diabetes, insulin climbs long before glucose does. Muscle, liver and fat tissue stop responding efficiently, so the pancreas compensates by secreting more, and fasting glucose stays deceptively normal for years. Measuring insulin catches the process in that silent window, when it is still highly reversible. Combined with fasting glucose it produces HOMA-IR, the standard research index of insulin resistance.
Why elevated insulin matters beyond diabetes
The Quebec Cardiovascular Study showed that fasting insulin predicted ischemic heart disease independently of cholesterol and blood pressure. Insulin is a growth signal as well as a glucose regulator, and chronic elevation is linked to fatty liver, ovarian cysts in PCOS, hypertension and accelerated cell growth. Lowering it through lifestyle does double duty, defusing both metabolic and cardiovascular risk.
Bringing insulin back to the quiet zone
Fasting insulin responds reliably to the classics, weight loss around the waist, resistance training that rebuilds glucose-hungry muscle, post-meal walking, adequate sleep and fewer refined carbohydrates. Time-restricted eating helps some people mainly by lengthening the daily window when insulin stays low. A repeat test after three months of change usually shows the trend clearly.
Related calculators
Related biomarkers Glucose · C-peptide · HbA1c · Triglycerides